» Articles » PMID: 16354847

Relationship Between Serum 25-hydroxyvitamin D and Pulmonary Function in the Third National Health and Nutrition Examination Survey

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2005 Dec 16
PMID 16354847
Citations 219
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Age, gender, height, ethnicity, and smoking are important determinants of lung function but do not explain all of the variation between individuals. Low concentrations of vitamin D have been associated with a number of diseases, including osteoporosis, hypertension, and type I diabetes. It is possible that serum concentrations of vitamin D might also influence pulmonary function.

Objectives: To determine the relationship between serum concentrations of 25-hydroxy vitamin D and pulmonary function.

Design, Setting And Participants: The analysis was conducted using data from the Third National Health and Nutrition Examination Survey, which was a cross-sectional survey of the US civilian population that was conducted from 1988 to 1994. The analyses were restricted to 14,091 people who > or = 20 years of age, were interviewed at mobile examination centers, and had undergone spirometry, and in whom serum 25-hydroxy vitamin D levels had been measured.

Results: After adjustment for age, gender, height, body mass index, ethnicity, and smoking history, the mean FEV1 was 126 mL (SE, 22 mL), and the mean FVC was 172 mL (SE, 26 mL) greater for the highest quintile of serum 25-hydroxy vitamin D level (> or = 85.7 nmol/L) compared with the lowest quintile (< or = 40.4 nmol/L; p < 0.0001). With further adjustment for physical activity, the intake of vitamin D supplements, milk intake, and the level of serum antioxidants, the mean difference between the highest and lowest quintiles of 25-hydroxy vitamin D was 106 mL (SE, 24 mL) for FEV1, and 142 mL (SE, 29 mL) for FVC (p < 0.0001).

Conclusions: There is a strong relationship between serum concentrations of 25-hydroxy vitamin D, FEV1, and FVC. Further studies are necessary to determine whether supplementation with vitamin D is of any benefit in patients with respiratory disease.

Citing Articles

Nonlinear association between serum 25-hydroxyvitamin D concentrations and lung function in the United States adult population with COPD.

Han Z, Yang J, Du Y, Wang J, Hu H, Xue X Sci Rep. 2025; 15(1):7474.

PMID: 40032920 PMC: 11876368. DOI: 10.1038/s41598-025-90354-z.


The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease.

Al-Jahdali H, Al-Lehebi R, Lababidi H, Alhejaili F, Habis Y, Alsowayan W Ann Thorac Med. 2025; 20(1):1-35.

PMID: 39926399 PMC: 11804957. DOI: 10.4103/atm.atm_155_24.


Association of Severe Vitamin D Deficiency with Hospitalization in the Previous Year in Hospitalized Exacerbated COPD Patients.

Li B, Liu M, Wang Y, Zhang H, Xuan L, Huang K Int J Chron Obstruct Pulmon Dis. 2024; 19:1471-1478.

PMID: 38948911 PMC: 11214566. DOI: 10.2147/COPD.S461029.


Nonlinear correlation and mediation effects between serum 25-hydroxyvitamin D levels and all-cause mortality in COPD patients.

Jiang Q, Jiang Y, Ma Z, Huang J, Li Y Front Nutr. 2024; 11:1412606.

PMID: 38903612 PMC: 11188383. DOI: 10.3389/fnut.2024.1412606.


Vitamin D and Insulin-Dependent Diabetes: A Systematic Review of Clinical Trials.

Dadon Y, Hecht Sagie L, Mimouni F, Arad I, Mendlovic J Nutrients. 2024; 16(7).

PMID: 38613075 PMC: 11013464. DOI: 10.3390/nu16071042.